Does Cardiovascular-Kidney-Metabolic syndrome increase the risk of incident cancer in individuals without prior cancer?
Advanced Cardiovascular-Kidney-Metabolic syndrome stages (3 and 4) are associated with a significantly increased risk of incident cancer, highlighting the need for integrated risk stratification.
sequencing offers broader detection and reanalysis benefits.Genetictrained nephrologist-led clinics achieve yield and uptake comparable to Multi-D models, yet evidence for mainstreaming remains sparse.Patient-reported and implementation outcomes are rarely capturedpriority gaps for future research.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
Azegami et al. (Wed,) studied this question.